دورية أكاديمية

Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study.

التفاصيل البيبلوغرافية
العنوان: Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study.
المؤلفون: Aly, Abdalla, Singh, Prianka, Korytowsky, Beata, Ling, You-Li, Kale, Hrishikesh P, Dastani, Homa B, Botteman, Marc F, Norden, Andrew D
المصدر: Neurooncol Pract ; ISSN:2054-2577 ; Volume:7 ; Issue:2
بيانات النشر: PubMed Central
سنة النشر: 2020
المجموعة: PubMed Central (PMC)
مصطلحات موضوعية: costs, glioblastoma, line of therapy, resource use, survival
الوصف: Glioblastoma (GBM) is associated with poor prognosis, large morbidity burden, and limited treatment options. This analysis evaluated real-world treatment patterns, overall survival, resource use, and costs among Medicare patients with GBM.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://doi.org/10.1093/nop/npz042Test; https://pubmed.ncbi.nlm.nih.gov/32626585Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318856Test/
DOI: 10.1093/nop/npz042
الإتاحة: https://doi.org/10.1093/nop/npz042Test
https://pubmed.ncbi.nlm.nih.gov/32626585Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318856Test/
حقوق: © The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
رقم الانضمام: edsbas.6F8B2803
قاعدة البيانات: BASE